Skip to main content
. 2020 May 26;8:411. doi: 10.3389/fbioe.2020.00411

FIGURE 2.

FIGURE 2

The administration of neutralizing antibodies against extracellular chaperones, in conjunction with the implantation of engineered cardiac tissues, may represent a new approach to dampen myocardial inflammation and improve the engraftment.